Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3390/nu12113361 http://scihub22266oqcxt.onion/10.3390/nu12113361 33142828!7692080!33142828     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Nutrients 2020 ; 12 (11): ä Nephropedia Template TP {{tp|p=33142828|t=2020. Evidence Regarding Vitamin D and Risk of COVID-19 and Its Severity |pdf=|usr=}}{{33142828}} gab.com Text Evidence Regarding Vitamin D and Risk of COVID-19 and Its Severity JO: Nutrients http://www.kidney.de/pget.php?&tw=1&pmid=33142828 #FOAvip Vitamin D deficiency co-exists in patients with COVID-19. At this time, dark skin color, increased age, the presence of pre-existing illnesses and vitamin D deficiency are features of severe COVID disease. Of these, only vitamin D deficiency is modifiable. Through its interactions with a multitude of cells, vitamin D may have several ways to reduce the risk of acute respiratory tract infections and COVID-19: reducing the survival and replication of viruses, reducing risk of inflammatory cytokine production, increasing angiotensin-converting enzyme 2 concentrations, and maintaining endothelial integrity. Fourteen observational studies offer evidence that serum 25-hydroxyvitamin D concentrations are inversely correlated with the incidence or severity of COVID-19. The evidence to date generally satisfies Hill's criteria for causality in a biological system, namely, strength of association, consistency, temporality, biological gradient, plausibility (e.g., mechanisms), and coherence, although experimental verification is lacking. Thus, the evidence seems strong enough that people and physicians can use or recommend vitamin D supplements to prevent or treat COVID-19 in light of their safety and wide therapeutic window. In view of public health policy, however, results of large-scale vitamin D randomized controlled trials are required and are currently in progress. Twit Text FOAVip Evidence Regarding Vitamin D and Risk of COVID-19 and Its Severity ????Nutrients http://www.kidney.de/pget.php?&tw=1&pmid=33142828 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33142828 #FOAvip English Wikipedia <ref>{{Cite pmid|33142828}}</ref> Evidence Regarding Vitamin D and Risk of COVID-19 and Its Severity #MMPMID33142828 Mercola J; Grant WB; Wagner CL Nutrients 2020[Oct]; 12 (11): ä PMID33142828show ga Vitamin D deficiency co-exists in patients with COVID-19. At this time, dark skin color, increased age, the presence of pre-existing illnesses and vitamin D deficiency are features of severe COVID disease. Of these, only vitamin D deficiency is modifiable. Through its interactions with a multitude of cells, vitamin D may have several ways to reduce the risk of acute respiratory tract infections and COVID-19: reducing the survival and replication of viruses, reducing risk of inflammatory cytokine production, increasing angiotensin-converting enzyme 2 concentrations, and maintaining endothelial integrity. Fourteen observational studies offer evidence that serum 25-hydroxyvitamin D concentrations are inversely correlated with the incidence or severity of COVID-19. The evidence to date generally satisfies Hill's criteria for causality in a biological system, namely, strength of association, consistency, temporality, biological gradient, plausibility (e.g., mechanisms), and coherence, although experimental verification is lacking. Thus, the evidence seems strong enough that people and physicians can use or recommend vitamin D supplements to prevent or treat COVID-19 in light of their safety and wide therapeutic window. In view of public health policy, however, results of large-scale vitamin D randomized controlled trials are required and are currently in progress. |*Betacoronavirus[MESH] |*Severity of Illness Index[MESH] |COVID-19[MESH] |Coronavirus Infections/*blood/mortality/virology[MESH] |Dietary Supplements[MESH] |Female[MESH] |Humans[MESH] |Male[MESH] |Observational Studies as Topic[MESH] |Pandemics[MESH] |Pneumonia, Viral/*blood/mortality/virology[MESH] |SARS-CoV-2[MESH] |Vitamin D Deficiency/*virology[MESH] |Vitamin D/*analogs & derivatives/blood/therapeutic use[MESH]Evidence Regarding Vitamin D and Risk of COVID-19 and Its Severity (epmc).pdf DeepDyve Pubget Overpricing